Efficacy and safety of ixekizumab in psoriatic patients: a long-term real-world retrospective multicenter study from Southern Italy.

IF 3.7 4区医学 Q1 DERMATOLOGY

Clinical and Experimental Dermatology Pub Date : 2024-11-26 DOI:10.1093/ced/llae519

Maria Letizia Musumeci, Andrea Calogero Trecarichi, Matteo Megna, Luca Potestio, Giuseppe Micali

引用次数: 0

查看原文本刊更多论文

ixekizumab对银屑病患者的疗效和安全性：一项来自意大利南部的长期真实世界回顾性多中心研究。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Clinical and Experimental Dermatology 医学-皮肤病学

CiteScore

3.20

自引率

2.40%

发文量

389

审稿时长

3-8 weeks

期刊介绍： Clinical and Experimental Dermatology (CED) is a unique provider of relevant and educational material for practising clinicians and dermatological researchers. We support continuing professional development (CPD) of dermatology specialists to advance the understanding, management and treatment of skin disease in order to improve patient outcomes.